This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (March 2024) |
Submission declined on 22 January 2024 by Spinster300 (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Submission declined on 6 November 2023 by Vanderwaalforces (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Vanderwaalforces 12 months ago. |
Submission declined on 2 November 2023 by CNMall41 (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by CNMall41 12 months ago. |
Submission declined on 13 July 2023 by Ca (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Ca 15 months ago. |
Submission declined on 15 March 2023 by Greenman (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Greenman 19 months ago. |
- Comment: Some paragraphs have misleading citations. — Preceding unsigned comment added by Ca (talk • contribs) 5:26 am, 13 July 2023 (UTC)
- Comment: Please add a source to verify claims like date of birth. Vanderwaalforces (talk) 23:00, 6 November 2023 (UTC)
Adam Bierman | |
---|---|
Nationality | American |
Education | |
Known for | former CEO, MedMen |
Adam Bierman is an American businessman and entrepreneur.[1] He is best known for co-founding the cannabis retailer MedMen with partner Andrew Modlin, where he was CEO from 2010 until 2020.[2]
Early life and education
editBierman was born in Scottsdale, Arizona. He attended Brandeis University in Waltham, Massachusetts for one year, then Los Angeles City College in order to pursue baseball more seriously. He transferred to USC, dropping out shortly after the transfer went through to build a sports agency.
Career
editMedMen
editAfter dabbling in the cannabis industry, in September 2012, Bierman and Modlin founded MedMen.[3] Bierman’s exclusive trade became legal marijuana.[4][5] The licensing applications for medical dispensaries in Massachusetts opened in 2013[6] and Bierman briefly did some consulting into the application process.[7] After realizing how the business model was moving forward in the cannabis industry, MedMen made the switch from consultancy to a management firm.[8][9]
Over the next decade, Bierman grew MedMen to five states,[10] with a total of 33 retail stores,[11] and over 1,500 employees. It also became a publicly traded company[12] with a $1.65 billion market cap.[13] In January 2020, Bierman agreed to step down from his role as CEO of MedMen to assume a more strategic board position.[14]
PharmaCann Acquisition
editIn late 2018, MedMen signed a deal to acquire PharmaCann for $682 million, the largest acquisition in U.S. cannabis history.[15] Bill Barr and the Department of Justice opposed the deal and [16] the merger was terminated in October 2019.[17]
Venture Funding and Capital Raises
editBierman was able to secure millions in venture funding for MedMen. In April 2016, Cap-Meridian Ventures invested $15 million.[18] Two months later, Bierman launched Opportunity Fund I, which raised $60 million in 9 months.[19] The following year, Opportunity Fund II launched, securing $75 million in 6 months.[20]
Bierman continued to pursue investments into MedMen in 2018. In October, Bierman secured a loan for $94 million,[21] one of the first true senior secured loans in cannabis. A few days later, the loan increased to $100 million.[22]
In March 2019, Bierman helped MedMen secure a $250 million investment deal with Gotham Green Partners,[23] which raised an additional $30 million in July. In December, Wicklow Partner also invested an additional $27 million.[24]
Legal issues
editBierman was the target of several allegations, ranging from mismanagement of money to personal biases. Most of these allegations arose out of a lawsuit in 2019 from former MedMen CFO Parker,[25] of which the jury ruled in favor of MedMen and Bierman.[26]
In January 2019, Bierman and Modlin were subjects of a lawsuit from a shareholder entity in MedMen, claiming breach of fiduciary duty.[27] The lawsuit was dismissed in June of the same year.[28]
In 2022, Bierman was awarded a $3 million total in his lawsuit against MedMen for wrongful termination.[29]
References
edit- ^ "MedMen Cannabis Dispensaries and Delivery Service". medmen.com. Retrieved 2024-01-12.
- ^ Wallace, Alicia (2020-01-31). "CEO of cannabis retailer MedMen steps down | CNN Business". CNN. Retrieved 2024-01-12.
- ^ "MMMG LLC". Bloomberg. Retrieved 19 July 2023.
- ^ Perry, Kevin EG; Perry, Kevin E. G. (2018-04-18). "I Went on a Tour of America's Biggest Legal Weed Factory". Vice. Retrieved 2024-01-12.
- ^ "The Business of Pot". TIME. 2015-04-09. Retrieved 2024-01-12.
- ^ "1st Medical Marijuana Applications Due In Mass". WBUR. 22 August 2013. Retrieved 15 March 2023.
- ^ Garman, Valerie. "Consultant calls Florida 'perfect storm' for marijuana business". Panama City News Herald. Retrieved 2024-01-12.
- ^ DiMartino, Mediha (2022-02-14). "MedMen Launches Concierge Service to Grow Retail Operations". Los Angeles Business Journal. Retrieved 2024-01-12.
- ^ Laporte, Nicole (March 15, 2018). "It's Happening: Will MedMen Become The Starbucks Of Weed?". Fast Company.
- ^ Waters, TaMaryn. "MedMen Enterprises medical marijuana dispensary opens in Midtown". Tallahassee Democrat. Retrieved 2 March 2023.
- ^ Mathis, Katie Brune (28 May 2019). "MedMen plans locations in Five Points, Jacksonville Beach". Jacksonville Daily Record. Retrieved 2 March 2023.
- ^ Bartholomew, Dana (2018-05-29). "Culver City-Based Medmen Enterprises Goes Public on Canadian Exchange". Los Angeles Business Journal. Retrieved 2024-01-12.
- ^ Grant, Kinsey (2018-05-30). "The Largest U.S. Cannabis Company Finds a Home on a Canadian Exchange". TheStreet. Retrieved 2024-01-12.
- ^ Wallace, Alicia (2020-01-31). "CEO of cannabis retailer MedMen steps down | CNN Business". CNN. Retrieved 2024-01-12.
- ^ Berke, Jeremy. "High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in history". Business Insider. Retrieved 2 March 2023.
- ^ "Attorney General Barr ordered cannabis merger investigation over staff objections, US DOJ whistleblower says". Mlex Market Insight. Retrieved 2 March 2023.
- ^ Amore, Samson (8 October 2019). "MedMen Terminates PharmaCann Purchase, CFO". LA Business Journal.
- ^ Staff, MJ Biz Daily. "MedMen Inks $15M in Financing for California Expansion". MJ Biz Daily. Retrieved 19 July 2023.
- ^ Chen, I-Chun. "Medmen Raises Additional $60 Million for Legal Marijuana Investment Fund". L.A. Business First. Retrieved 2 March 2023.
- ^ Kaufman, Karl. "How To Build A Marijuana Unicorn: An Interview With MedMen Spokesman Daniel Yi". Forbes. Retrieved 2 March 2023.
- ^ "MedMen Raises $94 Million with Senior Secured Term Loan at 7.5%". New Cannabis Ventures. Retrieved 2 March 2023.
- ^ Kelleher, Ellen (4 October 2018). "Cannabis company MedMen Enterprises closes additional tranche on term loan facility". ProActive. Retrieved 19 July 2023.
- ^ Staff, TRD (11 July 2019). "MedMen, the "Apple Store of Weed," gets $30M for pot retail push". The Real Deal. Retrieved 19 July 2023.
- ^ Amore, Samson. "MedMen Restructuring Brings $37 Million in Savings". Los Angeles Business Journal. Retrieved 19 July 2023.
- ^ Peltz, James F (24 February 2019). "Fast-growing pot seller MedMen faces lawsuit by former insider". LA Times. Retrieved 2 March 2023.
- ^ Borchardt, Debra (23 November 2021). "MedMen Wins Case Against Former CFO James Parker". Green Market Report. Retrieved 2 March 2023.
- ^ Staff. "Marijuana firm MedMen, top execs face $20 million suit for allegedly breaching duties, enriching selves". MJBiz Daily. Retrieved 2 March 2023.
- ^ "Litigious Investors Dismiss Faulty Court Action Against MedMen". Bloomberg. 6 June 2019. Retrieved 2 March 2023.
- ^ Gelsi, Steve. "Cannabis exec Adam Bierman wins MedMen arbitration settlement and eyes pot biz again". Marketwatch. Retrieved 19 July 2023.